FOLH1 and prostate carcinoma: When europium(III) was used as a luminescent surrogate metal ion, the binding affinity of Eu-L804-IAB2MA was measured in PSMA-positive PC3-PIP and PSMA-negative PC3-FLU prostate cancer cells by time-resolved luminescence.